Notably, increased expression of IL-8 has been found to be associated with multidrug resistance in breast cancer cells, sunitinib resistance in renal cell carcinoma, and RO4929097 (a γ-secretase inhibitor) resistance in NSCLC cells [36]. Here, CXCL8 is linked to breast carcinoma.